Kerri Truelock, MD
Gynecology · Kerrville, TXNPI 1750344883
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $907 and has fallen 67.0% since, to $299 in 2025.
Across 149 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$754
- Amgen$582
- Astellas Pharma US Inc$361
- Lilly USA, LLC$176
- Intuitive Surgical$171
- Urovant Sciences Inc$162
- plus $1K from 26 others
What the payments were for
- Travel & lodging$441%
- Food & beverage$3,25096%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $754 |
| Amgen | 28 | $582 |
| Astellas Pharma US Inc | 12 | $361 |
| Lilly USA, LLC | 4 | $176 |
| Intuitive Surgical | 2 | $171 |
| Urovant Sciences Inc | 3 | $162 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $156 |
| Mayne Pharma Commercial LLC | 7 | $130 |
| GSK | 1 | $125 |
| Exact Sciences | 5 | $97 |
| Therapeuticsmd, Inc. | 6 | $94 |
| Currax Pharmaceuticals LLC | 4 | $62 |
| BD | 1 | $58 |
| Novo Nordisk | 3 | $53 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Revance Therapeutics, Inc. | 1 | $29 |
| Acessa Health Inc. | 2 | $27 |
| Bausch Health US, LLC | 1 | $26 |
| Exeltis, USA Inc. | 1 | $23 |
| Pfizer | 1 | $22 |
| Novartis | 1 | $22 |
| Organon | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| Lupin Inc. | 1 | $13 |
| Aspira Women's Health Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,394 in reported general payments places this provider in the 75th percentile of 161 gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 283 | $18,985 |
| PremarinEstrogens, Conjugated | 17 | $7,256 |
| Estradiol (Twice Weekly)Estradiol | 41 | $5,534 |
| DottiEstradiol | 17 | $3,200 |
| ProgesteroneProgesterone, Micronized | 62 | $2,436 |
| Raloxifene Hcl | 34 | $1,849 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 15 | $1,671 |
| Estradiol (Once Weekly)Estradiol | 17 | $1,287 |
| Liothyronine Sodium | 22 | $1,002 |
| Clobetasol Propionate | 28 | $842 |
| Levothyroxine Sodium | 93 | $470 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 23 | $331 |
| Medroxyprogesterone Acetate | 31 | $291 |
| Solifenacin Succinate | 15 | $258 |
| ValacyclovirValacyclovir Hcl | 15 | $248 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $22 | $7,25617 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $15 | $47093 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 161 gynecology providers in Texas.
Other gynecology in Kerrville
- Richard FarnamEl Paso$1.2M
- Jessica ShepherdDallas$809K
- Linda LacyEl Paso$627K
- John WhitfieldFort Worth$141K
- Robert ZurawinHouston$61K
- Charles EubankCorpus Christi$51K
- Tiffany JacksonGarland$50K
- Cynthia Chaparro-KruegerAustin$41K
- Laura SheltonCorpus Christi$22K
- Nicolas XydasHouston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.